Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/1995
09/05/1995CA2010017C Composition for reparation and prevention of fibrotic lesions
09/05/1995CA1336911C Serotonin antagonists
09/05/1995CA1336906C Lactam derivatives
09/05/1995CA1336887C Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
09/05/1995CA1336886C Phenethanolamine and growth hormone combinations
09/04/1995CA2143691A1 Acetamides
09/03/1995CA2141999A1 Methods of use for inhibiting bone loss and lowering serum cholesterol
09/02/1995CA2143603A1 Fatty acid derivatives
08/1995
08/31/1995WO1995023216A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
08/31/1995WO1995023214A1 Method for stimulating profileration of colon cells using pomc¿76-103?
08/31/1995WO1995023213A1 Reproduction and utilization of functional human tissue
08/31/1995WO1995023161A1 Growth arrest homeobox gene
08/31/1995WO1995023160A1 Novel phosphoramidate and phophorothioamidate oligomeric compounds
08/31/1995WO1995023159A1 Novel bombesin-related peptides
08/31/1995WO1995023157A1 4-n-substituted sialic acids and their sialosides
08/31/1995WO1995023140A1 Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
08/31/1995WO1995023139A1 Optically pure 4-aryl-2-hydroxytetronic acids
08/31/1995WO1995022974A2 Film coated tablet of paracetamol and domperidone
08/31/1995WO1995022966A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
08/31/1995DE4406073A1 Verfahren zur Herstellung von humanen, klonogenen Fibroblasten, Verfahren zur Gentransfizierung von Fibroblasten und so erhaltene Fibroblasten A process for the production of human, clonogenic fibroblasts method for Gentransfizierung of fibroblasts and fibroblasts thus obtained
08/31/1995CA2184176A1 Method for stimulating profileration of colon cells using pomc76-103
08/31/1995CA2184093A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
08/31/1995CA2184068A1 Optically pure 4-aryl-2-hydroxytetronic acids
08/31/1995CA2183863A1 Growth arrest homeobox gene
08/31/1995CA2183556A1 Novel bombesin-related peptides
08/31/1995CA2183438A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
08/31/1995CA2181237A1 4-n-substituted sialic acids and their sialosides
08/30/1995EP0669333A1 New imidazopyridine derivatives as angiotensin II antagonists
08/30/1995EP0668879A1 Truncated insulin-like growth factor binding proteins having mitogenic activity
08/30/1995EP0668873A1 Antagonists of human gamma interferon
08/30/1995EP0668872A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma
08/30/1995EP0668871A1 Amino-acid sequence homologies between selectins and b. pertussis toxin-peptidesderived therfrom, antibodies thereto and pharmaceutical compositions
08/30/1995EP0668854A1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacentates or n, n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress
08/30/1995EP0668774A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis
08/30/1995EP0668771A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs
08/30/1995EP0668770A1 $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
08/30/1995EP0668769A1 Synthetic compositions related to oak bark extrakt, and method of using same
08/30/1995EP0668760A1 Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo
08/30/1995EP0428541B1 Collagen wound healing matrices and process for their production
08/30/1995CN1107475A Pyrrolidine derivatives inhibitors of lfukotriene biosynthesis
08/30/1995CN1107363A Alcohol or aldehyde derivatives and their use
08/30/1995CN1029613C Aryl oxime carbamates and aryl oxime carbonates as bronchodilators and auti-inflamatory agents
08/29/1995US5446189 Diester intermediates for diacid enzyme inhibitor
08/29/1995US5446161 Amino acid derivatives
08/29/1995US5446153 Intermediates for imidazo[4,5-c]pyridin-4-amines
08/29/1995US5446131 Polypeptides or cylic polypeptide; therapeutic and prophylactic; inhibit thrombin-induced platelet aggregation
08/29/1995US5446121 Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid
08/29/1995US5446091 Collagen-polymer conjugates containing an ether linkage
08/29/1995US5446049 Azanoradamantanes for treatment of conditions responsive to 5-HT agonists and/or antagonists
08/29/1995US5446046 1,3-dipropyl-8-(3-oxatricyclo(3,1,2,0(2,4-))oct6(7)-Yl)-xanthine used to treat cadiac arrhythmias
08/29/1995US5446035 Stabilize blood calcium and phosphate levels, induce cell differentiation
08/29/1995US5446034 Vitamin D analogues
08/29/1995US5445824 Vacuum extraction, solvent extraction or heating under reduced pressure yields carbohydrates, lipids, amino acids and inorganic compounds
08/29/1995US5445805 Large potassium bicarbonate crystals and process for the preparation thereof
08/29/1995CA1336825C Use and agent for reducing the side effects of tnf
08/29/1995CA1336816C Wound healing
08/25/1995CA2143412A1 Imidazopyridine derivatives as angiotensin ii antagonists
08/24/1995WO1995022611A2 Methods and compositions for stimulating bone cells
08/24/1995WO1995022546A1 Intracellular signalling mediators
08/24/1995WO1995022545A1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO[3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
08/24/1995WO1995022542A1 Phenylpyrrole derivatives and their use as dopamine d3 antagonists
08/24/1995WO1995022540A1 Enantiomerically pure (+)-liarozole
08/24/1995WO1995022350A1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/24/1995WO1995022329A1 Agent for prophylaxis and treatment of thromboxane a2-mediated diseases
08/24/1995WO1995022326A1 Cholinesterase activator
08/24/1995WO1995022322A1 Sexual steroid-containing transdermal therapeutic systems
08/24/1995WO1995022321A1 Desogestrel-containing transdermal application agent
08/24/1995DE4405899A1 Mittel zur transdermalen Applikation enthaltend Desogestrel Means for transdermal administration comprising desogestrel
08/24/1995DE4405898A1 Transdermale therapeutische Systeme enthaltend Sexualsteroide Transdermal therapeutic systems containing sex steroids
08/24/1995DE19505287A1 Zusammensetzung und Verfahren zur Prävention und Behandlung von Entzündungen mit Immunglobulin A A composition and method for the prevention and treatment of inflammation with immunoglobulin A
08/24/1995CA2183571A1 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
08/24/1995CA2183566A1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/24/1995CA2183562A1 Intracellular signalling mediators
08/24/1995CA2183544A1 Desogestrel-containing transdermal application agent
08/24/1995CA2182882A1 Cholinesterase activator
08/24/1995CA2182583A1 Enantiomerically pure (+)-liarozole
08/23/1995EP0668279A2 6-Azaindole thromboxane synthase inhibitors
08/23/1995EP0668075A2 Non-peptide tachykinin receptor antagonists
08/23/1995EP0667911A1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase
08/23/1995EP0667901A1 Novel cytokine
08/23/1995EP0667870A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b)
08/23/1995EP0667867A1 Piperidine derivatives as 5-ht4 receptor antagonists
08/23/1995EP0667858A1 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists
08/23/1995EP0667857A1 Indolylcarbamates as anti-inflammatory agents
08/23/1995EP0667856A1 Novel vitamin d analogues
08/23/1995EP0667855A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
08/23/1995EP0667854A1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences
08/23/1995EP0667791A1 Isolation, growth, differentiation and genetic engineering of human muscle cells
08/23/1995EP0667784A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
08/23/1995EP0667780A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents
08/23/1995EP0667770A1 Inhibition of tnf production.
08/23/1995EP0667769A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
08/23/1995EP0500653A4 Inhibitors of purine nucleoside phosphorylase
08/23/1995CN1107159A Linear adhesion inhibitors
08/23/1995CN1107149A 哌嗪衍生物 Piperazine derivatives
08/23/1995CN1107144A Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
08/23/1995CN1107137A Novel carboxylate derivatives exhibiting phospholipase A2 inhibitery a ctivity
08/23/1995CA2141987A1 Organopathy preventing, curing or ameliorating agent
08/22/1995US5444158 Merosin, nucleic acids encoding, fragments and uses thereof
08/22/1995US5444090 Applying a synthetase inhibitor
1 ... 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 ... 1564